MXPA06000995A - Novel n. - Google Patents

Novel n.

Info

Publication number
MXPA06000995A
MXPA06000995A MXPA06000995A MXPA06000995A MXPA06000995A MX PA06000995 A MXPA06000995 A MX PA06000995A MX PA06000995 A MXPA06000995 A MX PA06000995A MX PA06000995 A MXPA06000995 A MX PA06000995A MX PA06000995 A MXPA06000995 A MX PA06000995A
Authority
MX
Mexico
Prior art keywords
novel
tumors
medicament
treatment
production
Prior art date
Application number
MXPA06000995A
Other languages
Spanish (es)
Inventor
Peter Schmidt
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of MXPA06000995A publication Critical patent/MXPA06000995A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to novel N-substituted indolyl-3-glyoxylic acid amides of general formula (I), the production thereof, and the use thereof as a medicament, especially for the treatment of tumors.
MXPA06000995A 2003-07-25 2004-07-09 Novel n. MXPA06000995A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10334040A DE10334040A1 (en) 2003-07-25 2003-07-25 Novel N-substituted indolyl-3-glyoxylic acid amides, their use as medicaments and process for their preparation
PCT/EP2004/007573 WO2005014542A2 (en) 2003-07-25 2004-07-09 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament against cancer, and method for the production thereof

Publications (1)

Publication Number Publication Date
MXPA06000995A true MXPA06000995A (en) 2006-04-11

Family

ID=34129467

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000995A MXPA06000995A (en) 2003-07-25 2004-07-09 Novel n.

Country Status (18)

Country Link
EP (1) EP1651600A2 (en)
JP (1) JP2007503376A (en)
KR (1) KR20060037398A (en)
CN (1) CN1839129A (en)
AR (1) AR045928A1 (en)
AU (1) AU2004263238A1 (en)
BR (1) BRPI0412898A (en)
CA (1) CA2533433A1 (en)
DE (1) DE10334040A1 (en)
IL (1) IL173335A0 (en)
MX (1) MXPA06000995A (en)
NO (1) NO20060697L (en)
RS (1) RS20060049A (en)
RU (1) RU2317293C9 (en)
TW (1) TW200524863A (en)
UA (1) UA83498C2 (en)
WO (1) WO2005014542A2 (en)
ZA (1) ZA200601300B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660704A1 (en) 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
AR084433A1 (en) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc FAAH INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022280A2 (en) * 2001-09-13 2003-03-20 Synta Pharmaceuticals Corp. 3-glyoxlylamideindoles for treating cancer

Also Published As

Publication number Publication date
WO2005014542A2 (en) 2005-02-17
CN1839129A (en) 2006-09-27
RU2317293C9 (en) 2008-05-10
CA2533433A1 (en) 2005-02-17
RU2006105708A (en) 2006-06-27
AR045928A1 (en) 2005-11-16
ZA200601300B (en) 2007-03-28
IL173335A0 (en) 2006-06-11
EP1651600A2 (en) 2006-05-03
KR20060037398A (en) 2006-05-03
JP2007503376A (en) 2007-02-22
DE10334040A1 (en) 2005-03-10
NO20060697L (en) 2006-02-14
BRPI0412898A (en) 2006-10-03
TW200524863A (en) 2005-08-01
WO2005014542A3 (en) 2006-10-19
RU2317293C2 (en) 2008-02-20
UA83498C2 (en) 2008-07-25
RS20060049A (en) 2008-08-07
AU2004263238A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
PL1758852T3 (en) Substituted cyclopentene compounds
SE0200920D0 (en) Novel compounds
TW200616995A (en) Novel compounds
MXPA05010712A (en) Quinoline-2-one-derivatives for the treatment of airways diseases.
MX2007000505A (en) Substituted oxindol derivatives and medicaments containing the same.
MX2007003031A (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases.
PT1902037E (en) 2,4-diamino-pyrimidines used as aurora inhibitors
HK1094425A1 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
TW200630374A (en) Thiazolyldihydroindazoles
SI1613304T1 (en) Dpp-iv inhibitors
IL176111A0 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
MXPA05011707A (en) Substituted dihydrochinazolines having antiviral properties.
TW200635917A (en) Novel compounds
UA83233C2 (en) Substituted 2-aminotetralin for the treatment of depression
TW200605888A (en) Novel compounds
TW200740781A (en) Novel compounds
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
TW200635916A (en) Compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
MY146802A (en) Novel drugs for treating respiratory diseases
MXPA05010020A (en) Oxamide derivatives useful as raf-kinase inhibitors.
TW200719889A (en) Amino acid derivatives
MXPA06004308A (en) Isopentyl carboxanilides for combating undesired micro-organisms.